Target intelligence / Profile preview

Disintegrin and metalloproteinase domain-containing protein 2 (ADAM2)

Target
ADAM2
Molecular classification
Enzyme (metalloprotease family, largely non-catalytic in humans), Membrane-anchored protein, Disintegrin family (cell adhesion molecules), Sperm membrane protein
01

Overview

Disintegrin and metalloproteinase domain-containing protein 2 (ADAM2), also known as Beta-fertilin, is a member of the ADAM (A Disintegrin And Metalloproteinase) family of membrane-anchored glycoproteins. ADAM2 is prominently expressed in testicular tissue and plays a key role in male reproduction in many mammals by mediating sperm-egg adhesion and membrane fusion events required for fertilization[2][3][4]. It forms heterodimeric complexes (e.g., fertilin) with other ADAM family members (such as ADAM1/alpha-fertilin) and is essential for proper sperm function and migration through the female reproductive tract in animal models[2]. In mice, disruption of ADAM2 leads to infertility, establishing its necessity for reproduction in these species[2]. In humans, ADAM2 is present in testis but appears to be minimally or not at all expressed on mature sperm, suggesting that its reproductive function may have diverged in primates[2]. ADAM2 belongs to the metzincin clan of metalloproteinases but is typically a non-catalytic member in humans, retaining instead a prominent disintegrin domain involved in cell-cell recognition, particularly binding sperm to egg integrins[4][3]. Some isoforms have been identified as cancer/testis antigens, giving them potential biomarker utility[4]. There are no known drugs that target ADAM2, and it is not currently considered a therapeutic target for small molecules or biologics.

Other names
Beta-fertilinFertilin subunit betaPH-30PH30-betaCancer/testis antigen 15FTNBCT15CRYN1CRYN2PH-30b
02

Biological functions

Sperm-egg plasma membrane adhesion and fusion (fertilization)Sperm-zona bindingSperm migration in the female reproductive tractCell-cell and cell-matrix interactionsComplex formation with other ADAM proteins in sperm maturationProtein-protein interactions via integrin-binding (disintegrin domain)
03

Disease associations

Reproductive disorders (male infertility in animal models)Potential role as a cancer/testis antigen (biomarker function, not a primary disease driver)Diseases associated: Meckel syndrome type 3Severe congenital neutropenia 4
04

Safety considerations

No major therapeutic safety concerns documented since not a current drug target and is not expressed in most somatic human tissues (mainly testis-specific)
05

Biomarkers

May be considered a cancer/testis antigen biomarker in certain tissues

Beyond the preview

Go deeper on Disintegrin and metalloproteinase domain-containing protein 2 (ADAM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disintegrin and metalloproteinase domain-containing protein 2 (ADAM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call